Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic Repositioning
June 03, 2021 07:30 ET
|
Auris Medical AG
Entering field of RNA therapeutics through acquisition of Trasir Therapeutics, Inc.Trasir’s innovative peptide-based OligoPhoreTM platform designed to enable extrahepatic delivery of...